홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

1,4-Dichloro-2-butene, (2E)- → trans-7-{4-[4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-but-2-enyloxy}-2-methyl-benzothiazole

HRID 366428
노트
인쇄 미리보기

반응식

HRID 366428 반응식
[Cl:1]/[CH:2]=[CH:3]/[CH2:4][O:5][C:6]1[C:14]2[S:13][C:12]([CH3:15])=[N:11][C:10]=2[CH:9]=[CH:8][CH:7]=1.[CH:16]1[C:26]2[CH2:25][CH2:24][C:23]3[CH:27]=[CH:28][CH:29]=[CH:30][C:22]=3[CH:21]([N:31]3[CH2:36][CH2:35][NH:34][CH2:33][CH2:32]3)[C:20]=2[CH:19]=[CH:18][CH:17]=1.Cl[CH2:38]/C=C/CCl>>[CH:27]1[C:23]2[CH2:24][CH2:25][C:26]3[CH:16]=[CH:17][CH:18]=[CH:19][C:20]=3[CH:21]([N:31]3[CH2:32][CH2:33][N:34]([CH2:38]/[CH:2]=[CH:3]/[CH2:4][O:5][C:6]4[C:14]5[S:13][C:12]([CH3:15])=[N:11][C:10]=5[CH:9]=[CH:8][CH:7]=4)[CH2:35][CH2:36]3)[C:22]=2[CH:30]=[CH:29][CH:28]=1.[Cl:1]/[CH:2]=[CH:3]/[CH2:4][O:5][C:6]1[C:14]2[S:13][C:12]([CH3:15])=[N:11][C:10]=2[CH:9]=[CH:8][CH:7]=1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 6421971,4-Dichloro-2-butene, (2E)-HCID 27359361-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)piperazineHCID 23289321trans-7-(3-Chloroallyloxy)-2-methyl-benzothiazole

생성물 2

HCID 23289240trans-7-{4-[4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-piperazin-1-yl]-but-2-enyloxy}-2-methyl-benzothiazoleHCID 23289321trans-7-(3-Chloroallyloxy)-2-methyl-benzothiazole

실험 절차

The title compound was prepared according to Method GA from trans-7-(3-chloro-allyloxy)-2-methyl-benzothiazole and 1-(10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-yl)piperazine. mp 151-152° C.; LSIMS m/z 496. The trans-7-(3-chloroallyloxy)-2-methyl-benzothiazole was prepared by Method IV with trans-1,4-dichloro-2-butene as the alkylating agent.

출처 및 근거

ORD 기록
ord-0ee17759ccbc4c78b10e19e429ca0ccc
출처 데이터셋
uspto-grants-2000_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06130217

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트